ATE96035T1 - Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs. - Google Patents
Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.Info
- Publication number
- ATE96035T1 ATE96035T1 AT90403174T AT90403174T ATE96035T1 AT E96035 T1 ATE96035 T1 AT E96035T1 AT 90403174 T AT90403174 T AT 90403174T AT 90403174 T AT90403174 T AT 90403174T AT E96035 T1 ATE96035 T1 AT E96035T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- preparation
- treatment
- primitive
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR898914780A FR2654343B1 (fr) | 1989-11-10 | 1989-11-10 | Utilisation d'un polypeptide ayant l'activite de l'interferon gamma pour la preparation de compositions pharmaceutiques destinees au traitement de cancers primitifs de la plevre. |
EP90403174A EP0427633B1 (de) | 1989-11-10 | 1990-11-08 | Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE96035T1 true ATE96035T1 (de) | 1993-11-15 |
Family
ID=9387288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90403174T ATE96035T1 (de) | 1989-11-10 | 1990-11-08 | Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5108743A (de) |
EP (1) | EP0427633B1 (de) |
JP (1) | JPH07103042B2 (de) |
KR (1) | KR0169975B1 (de) |
AT (1) | ATE96035T1 (de) |
AU (1) | AU645042B2 (de) |
CA (1) | CA2029670A1 (de) |
DE (1) | DE69004051T2 (de) |
DK (1) | DK0427633T3 (de) |
FR (1) | FR2654343B1 (de) |
HU (1) | HU206049B (de) |
IL (1) | IL96229A (de) |
OA (1) | OA09469A (de) |
ZA (1) | ZA907649B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2482687C (en) * | 2003-09-29 | 2012-11-20 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of mesothelioma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE50694T1 (de) * | 1985-10-15 | 1990-03-15 | Hoffmann La Roche | Stabilisierung von interferonen. |
EP0302862A1 (de) * | 1986-03-17 | 1989-02-15 | Schering Corporation | Behandlung von krebs mit gamma-interferon |
ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
EP0278715A3 (de) * | 1987-02-09 | 1989-03-08 | Schering Corporation | Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen |
-
1989
- 1989-11-10 FR FR898914780A patent/FR2654343B1/fr not_active Expired - Fee Related
-
1990
- 1990-09-25 ZA ZA907649A patent/ZA907649B/xx unknown
- 1990-10-30 US US07/605,986 patent/US5108743A/en not_active Expired - Lifetime
- 1990-11-02 IL IL96229A patent/IL96229A/en not_active IP Right Cessation
- 1990-11-08 DK DK90403174.7T patent/DK0427633T3/da active
- 1990-11-08 AT AT90403174T patent/ATE96035T1/de not_active IP Right Cessation
- 1990-11-08 EP EP90403174A patent/EP0427633B1/de not_active Expired - Lifetime
- 1990-11-08 DE DE90403174T patent/DE69004051T2/de not_active Expired - Lifetime
- 1990-11-08 JP JP2301245A patent/JPH07103042B2/ja not_active Expired - Lifetime
- 1990-11-09 AU AU66511/90A patent/AU645042B2/en not_active Ceased
- 1990-11-09 OA OA59887A patent/OA09469A/xx unknown
- 1990-11-09 KR KR1019900018127A patent/KR0169975B1/ko not_active IP Right Cessation
- 1990-11-09 CA CA002029670A patent/CA2029670A1/fr not_active Abandoned
- 1990-11-16 HU HU907180A patent/HU206049B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH07103042B2 (ja) | 1995-11-08 |
US5108743A (en) | 1992-04-28 |
ZA907649B (en) | 1991-11-27 |
AU6651190A (en) | 1991-05-16 |
DE69004051D1 (de) | 1993-11-25 |
IL96229A (en) | 1998-04-05 |
FR2654343A1 (fr) | 1991-05-17 |
HU907180D0 (en) | 1991-05-28 |
IL96229A0 (en) | 1991-08-16 |
HUT55995A (en) | 1991-07-29 |
DE69004051T2 (de) | 1994-03-03 |
HU206049B (en) | 1992-08-28 |
OA09469A (fr) | 1992-11-15 |
JPH03188025A (ja) | 1991-08-16 |
AU645042B2 (en) | 1994-01-06 |
DK0427633T3 (da) | 1994-01-31 |
KR0169975B1 (ko) | 1999-02-01 |
CA2029670A1 (fr) | 1991-05-11 |
FR2654343B1 (fr) | 1994-08-05 |
KR910009280A (ko) | 1991-06-28 |
EP0427633B1 (de) | 1993-10-20 |
EP0427633A1 (de) | 1991-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
FI922151A0 (fi) | Metall-peptidkompositioner och metoder foer stimulering av haortillvaext. | |
GR3007096T3 (de) | ||
FR2483926B1 (de) | ||
DE59000270D1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
NL300106I2 (nl) | N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen. | |
DE59101397D1 (de) | O-glycosyliertes ifn-alpha. | |
DE69100364D1 (de) | Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung. | |
ATE54826T1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
ATE83378T1 (de) | Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen. | |
ATE127020T1 (de) | Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung. | |
ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
FI101597B1 (fi) | Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
DE69004794D1 (de) | Verwendung eines Polypeptids mit Interleukin 2-Aktivität zur Herstellung einer zur Behandlung von einfachen Pleurageschwüren bestimmten pharmazeutischen Zusammensetzung. | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
ZA81927B (en) | Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds | |
ATE96035T1 (de) | Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs. | |
DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
GR3005231T3 (de) | ||
ATE107166T1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. | |
DE3879709D1 (de) | Platin-arzneimittel. | |
DE69203098D1 (de) | Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen. | |
IT1238350B (it) | Composizione per la profilassi anticarie dello smalto umano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
EELA | Cancelled due to lapse of time |